Cancer, this one ailment has made millions of people in the USA suffer and continues to wreak havoc in the lives of thousands of people every year. It is estimated that approximately 40% of Americans are likely to get cancer at some stage in their life. While people have actively started living an active and healthy lifestyle, sometimes this is not enough. Genetic markers along with various environmental factors can lead to even the most careful people getting afflicted with this illness. There is hope though as a few companies such as Tempus, work on a continual basis to ensure that the medical sector gets access to futuristic technology that can help them win the battle against cancer.
Tempus is led by Eric Lefkofsky, and as the co-founder of this foundation, he and his team are in charge of building data enabled precision devices that can help with early diagnosis and accurate treatments for cancer. The tools that are being built by Eric Lefkofsky and his team that can input, calculate, correlate data and provides practical solutions for the American health industry.
The units built by Tempus changed the way data is collected, computed and transformed into usable information. The platform that has been designed by Eric Lefkofsky and his team computes a patient’s clinical data as well as any available molecule data. While there were many challenges faced by Tempus to get access to actual data of patients, these obstacles were slowly and steadily overcome. After gaining access to data, the next challenged faced by this firm was to compute the data so that usable information could be acquired. Since information about patients was available through various sources not limited to doctor’s notes and progress notes, Eric Lefkofsky and his team created a software program that could read large chunks of information while keeping specific considerations in mind. Both language processing and optical character recognition capabilities were built into the software which made it both efficient and reliable.
After putting in years of efforts in further perfecting the system, it is now possible for information related to genomes along with other genetic markers to be calculated using the Data Enabled Precision Machines created by Eric Lefkofsky and his team.
Eric Lefkofsky started his journey in his battle against cancer when his wife was diagnosed with breast cancer. Due to his first-hand experience, being a caretaker for a cancer patient he noticed the large gap between the processes of collecting data and computing it to get usable results. The personal struggle inspired him to build a system that is effective and provides concise solutions that can be used to formulate technologically advanced treatment plans.
In 2006, Eric Lefkofsky founded the Lefkofsky Family Foundation. This trust is charitable and is aimed at creating high impact techniques to improve the lives of people who are affected by Cancer. Both Eric Lefkofsky and his wife Liz believe in their cause and are dedicated to improving the lives of millions of cancer patients in the years to come.